Press releases

Novamind to Participate in MAPS Canada Webinar on Eating Disorders and PTSD

November 24, 2020

Novamind Closes Oversubscribed CAD$10 Million Private Placement

November 23, 2020

Novamind and Hinterland Metals Enter into Amalgamation Agreement

November 17, 2020

Novamind Supports Oregon Measure 109 to Responsibly Expand Patient Access to Psilocybin Therapy

November 10, 2020

Novamind to Introduce Novel Psychedelic Treatment Protocol in Online Workshop

November 09, 2020

Novamind to Discuss the Role of Ketamine in Eating Disorder Treatment at Leading Psychiatry Conference

November 05, 2020

Novamind to Present at PsyTech Summit

October 26, 2020

Novamind Appoints Dr. Reid Robison as Chief Medical Officer

August 28, 2020

Novamind Sponsors TheraPsil, an Advocate for the Compassionate Use of Psilocybin in Canada

July 31, 2020

Novamind Closes the Acquisition of Cedar Psychiatry, a Leading Psychedelic Therapy Organization in the U.S.

July 30, 2020

Novamind Announces Closing of Oversubscribed Private Placement

July 14, 2020

Hinterland Metals Inc. Signs Letter of Intent with Novamind Ventures Inc.

July 06, 2020

Buzz Capital and Novamind Terminate Letter of Intent

June 16, 2020

Novamind and Buzz Capital Announce Qualifying Transaction

May 18, 2020

Novamind Signs LOI to Acquire Cedar Psychiatry, a Leading Psychedelic Therapy and Research Organization in the United States

March 24, 2020

Novamind Announces Strategic Investment in the Synthesis Institute, a Renowned Legal Psilocybin Retreat in the Netherlands

November 18, 2019

Novamind Commits Initial Funding to Facilitate Safe, Legal Psychedelic Experiences

November 15, 2019

Novamind to Assess Opportunities in the Psychedelic Industry

May 22, 2019